Risk-adapted chemotherapy without procarbazine in treatment of children with Hodgkin lymphoma.

Abstract

BACKGROUND Because procarbazine is not available in the mainland of China, a risk-adapted chemotherapy without the drug was adopted for children with Hodgkin lymphoma (HL) in two tertiary referral centers for childhood cancer in Shanghai. The objective of the present study was to obtain the results comparable with those of previous studies. METHODS From… (More)
DOI: 10.1007/s12519-012-0390-0

4 Figures and Tables

Topics

  • Presentations referencing similar topics